The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s93, 2020. DOI: 10.25251/skin.4.supp.93. Disponível em: https://skin.dermsquared.com/skin/article/view/1063. Acesso em: 5 oct. 2025.